Clinical Trial Update: Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing aromatase inhibition versus testosterone in older men with low testosterone; results completed with posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Hypogonadism
• Major Depressive Disorder
• Osteoporosis
• Sarcopenia

Drugs mentioned

• Aromatase inhibitor (Aromatase inhibitor)
• TESTOSTERONE (testosterone)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Hypogonadism, Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2016-03-09